Complementary Healthcare Analysis - 2019-09-09

Sep. 09, 2019 11:07 AM ETACAD, ALKS, ARDX, AVTX, CLVS, CPRX, CYTK, DRRX, EIDX, ENDPQ, ENDV, ESPR, HQY, KMPH, LCI, MRNS, MRTX, NTGN, PBYI, RGEN, SRPT, TCDA, TLRY, URGN, VERU, WCG
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Long/Short Equity, Healthcare, Biotech

Contributor Since 2017

Avisol Capital Partners runs the Total Pharma Tracker Seeking Alpha Marketplace service. This is managed by Dr Asok Dutta, BVScAH and Dr Udaya Kumar Maiya, MD Oncologist. The service offers end-to-end research on both investing and trading ideas everyday, and includes a 150-stock watchlist and two 40-stock model portfolios that are continuously tracked.

Dr Dutta is a retired veterinary surgeon. He has over 40 years experience in the industry. Dr Maiya is a well-known oncologist who has 30 years in the medical field, including as Medical Director of various healthcare institutions. Both doctors are also avid private investors. They are assisted by a number of finance professionals in developing this service.

If you want to check out our service, go here - https://seekingalpha.com/author/avisol-capital-partners/research

Disclaimer - we are not investment advisors.
Top Gainers
Company Market Cap Price Change% Volume
ACADIA Pharmaceuticals Inc. (ACAD) 3.54B 38.79 63.00% 10,528,379
Marinus Pharmaceuticals, Inc. (MRNS) 90.86M 1.82 5.20% 652,645
Ardelyx, Inc. (ARDX) 314.60M 5.13 5.37% 508,194
Mirati Therapeutics, Inc. (MRTX) 3.37B 91.72 5.10% 485,079
Top Losers
Company Market Cap Price Change% Volume
Endo International plc (ENDP) 534.29M 3.03 -13.20% 5,169,962
Tilray, Inc. (TLRY) 3.13B 30.12 -6.06% 976,496
Akorn, Inc. (AKRX) 336.79M 2.52 -5.09% 767,062
Neon Therapeutics, Inc. (NTGN) 82.58M 3.01 -9.61% 618,042
Repligen Corporation (RGEN) 4.86B 81.90 -11.96% 443,360
High volume stocks reaching new highs
Company Market Cap Price Change% Volume
ACADIA Pharmaceuticals Inc. (ACAD) 3.54B 39.12 64.37% 11,050,478
Catalyst Pharmaceuticals, Inc. (CPRX) 643.30M 6.68 1.14% 561,092
DURECT Corporation (DRRX) 318.60M 1.83 2.81% 360,889
High volume stocks reaching new lows
Company Market Cap Price Change% Volume
Advaxis, Inc. (OTCQX:ADXS) 5.80M 0.31 -8.83% 2,340,192
Major Analyst Upgrades
Company Current Rating New Rating Analyst Current Price Target Price
Healthequity (HQY) Outperform Strong-Buy Raymond James $57.78 $80.00
Mirati Therapeutics (MRTX) Hold Buy Jefferies Financial Group $93.32 $105.00
Major Analyst Downgrades
Company Current Rating New Rating Analyst Current Price Target Price
WellCare Health Plans (WCG) Overweight Equal Stephens $268.08 $317.00
Major Insider Buys
Company Insider Name Insider Title Price Qty Value
Cerecor Inc. (CERC) Armistice Capital, LLC Dir, 10% $3.05 2200000 +$6,706,000
Endonovo Therapeutics, Inc. (OTCQB:ENDV) Collier Alan Brian CEO $0.01 114000 +$1,113
Esperion Therapeutics, Inc. (ESPR) Biotech Target N V 10% $33.78 80000 +$2,702,208
Mayleben Timothy M Pres, CEO $34.55 7500 +$259,107
Kempharm, Inc (KMPH) Clifton R. Laduane CFO, Secretary, Treasurer $0.77 850 +$652
Sarepta Therapeutics, Inc. (SRPT) Behrens M Kathleen Dir $87.98 2500 +$219,950
Major Insider Sells
Company Insider Name Insider Title Price Qty Value
Alkermes Plc. (ALKS) Pops Richard F Dir, CEO, Alkermes plc $20.18 -100000 -$2,017,830
Clovis Oncology, Inc. (CLVS) Gross Paul Edward See Remarks $5.21 -495 -$2,579
Ivers-Read Gillian C See Remarks $5.21 -630 -$3,282
Muehl Daniel W See Remarks $5.21 -495 -$2,579
Rolfe Lindsey See Remarks $5.21 -716 -$3,730
Cytokinetics Inc (CYTK) Malik Fady Ibraham EVP Research, Development $13.69 -1500 -$20,531
Eidos Therapeutics, Inc. (EIDX) Turtle Cameron Chief Business Officer $41.58 -5000 -$207,923
Lannett Co Inc (LCI) Paonessa Albert III Dir $10.30 -11582 -$119,295
Puma Biotechnology, Inc. (PBYI) Auerbach Alan H Pres, CEO, 10% $10.14 -524 -$5,313
Tricida, Inc. (TCDA) Stahl Wilhelm Chief Tech Officer, SVP $33.26 -2000 -$66,525
Urogen Pharma Ltd. (URGN) Schoenberg Mark Chief Medical Officer $33.92 -343 -$11,635
Veru Inc. (VERU) Steiner Mitchell Shuster Pres, CEO, 10% $1.93 -30000 -$57,919

Index Watch

NASDAQ Health CareINDEXNASDAQ: IXHC

image.png

iShares NASDAQ Biotechnology Index

NASDAQ: IBB

image.png

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.